Efficacy of Vestipitant, A Neurokinin-1 Receptor Antagonist, in Primary Insomnia-Reference-Cited by-同舟云学术

Efficacy of Vestipitant, A Neurokinin-1 Receptor Antagonist, in Primary Insomnia

Published:2013-12-01 Issue:12 Volume:36 Page:1823-1830
ISSN:0161-8105
Container-title:Sleep
language:en
Short-container-title:

Author:

Ratti Emiliangelo¹,Carpenter David J.²,Zamuner Stefano¹,Fernandes Sofia¹,Squassante Lisa¹,Danker-Hopfe Heidi³,Archer Graeme⁴,Robertson Jonathan⁴,Alexander Robert²,Trist David G.¹,Merlo-Pich Emilio¹

Affiliation:

1. GlaxoSmithKline Neuroscience Centre of Excellence for Drug Discovery, Verona, Italy

2. GlaxoSmithKline Discovery Medicine, Neurosciences Centre for Excellence in Drug Discovery, Philadelphia, PA

3. Competence Centre of Sleep Research and Sleep Medicine, Charité - University Medicine Berlin, Berlin, Germany

4. GlaxoSmithKline (GSK), Neurosciences Discovery Biometrics, Harlow, UK

Publisher

Oxford University Press (OUP)

Subject

Physiology (medical),Clinical Neurology

Link

http://academic.oup.com/sleep/article-pdf/36/12/1823/26661825/aasm.36.12.1823.pdf

Reference46 articles.

1. Insomnia

2. Clinical guideline for the evaluation and management of chronic insomnia in adults;Schutte-Rodin;J Clin Sleep Med,2008

3. Epidemiology of insomnia: what we know and what we still need to learn;Ohayon;Sleep Med Rev,2002

4. The evolution and development of insomnia pharmacotherapies,2007

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Elinzanetant for the Treatment of Vasomotor Symptoms Associated With Menopause;JAMA;2024-08-22

2. Elinzanetant, a new combined neurokinin-1/-3 receptor antagonist for the treatment of postmenopausal vasomotor symptoms;Expert Opinion on Pharmacotherapy;2024-05-02

3. Elinzanetant: a phase III therapy for postmenopausal patients with vasomotor symptoms;Expert Opinion on Investigational Drugs;2024-01-02

4. New advances in menopause symptom management;Best Practice & Research Clinical Endocrinology & Metabolism;2024-01

5. Asymmetric Construction of α,α‐Disubstituted Piperazinones Enabled by Benzilic Amide Rearrangement;Angewandte Chemie International Edition;2023-03-24